In the latter, for example, a prompt inhibition of insulin secretion and a promotion of secretion of counterregulatory hormones (such as glucagon or epineprhine) before starting exercise can considerably improve the control of glucose levels and reducing the risk of hypoglycemic events, especially for type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.